Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « Keywords » - entrée « Antiviral Agents (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral Agents (chemistry) < Antiviral Agents (pharmacology) < Antiviral Agents (supply & distribution)  Facettes :

List of bibliographic references indexed by Antiviral Agents (pharmacology)

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000217 (2020) David CyranoskiThis scientist hopes to test coronavirus drugs on animals in locked-down Wuhan.
000402 (2020) Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
000564 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000834 (2020) Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Discovering drugs to treat coronavirus disease 2019 (COVID-19).
000A37 (2020) Ewen Callaway ; David CyranoskiChina coronavirus: Six questions scientists are asking.
000D17 (2019) Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite]Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents.
000D74 (2019) Ayman M S. Ahmed [Égypte] ; Reham A I. Abou-Elkhair [Égypte] ; Alaa M. El-Torky [Égypte] ; Abdalla E A. Hassan [Égypte]3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.
001255 (2013) Mi Kyoung Kim [Corée du Sud] ; Hyunjun Yoon ; Dale Lynn Barnard ; Youhoon ChongDesign, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
001339 (2012) Dirk Jochmans [Belgique] ; Pieter Leyssen ; Johan NeytsA novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE.
001340 (2012) Anna-Winona Struck [Allemagne] ; Marco Axmann ; Susanne Pfefferle ; Christian Drosten ; Bernd MeyerA hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.
001371 (2011) S K Krishnan [Inde] ; S. Ganguly ; R. Veerasamy ; B. JanSynthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones.
001454 (2010) Krishnan Suresh Kumar [Inde] ; Swastika Ganguly ; Ravichandran Veerasamy ; Erik De ClercqSynthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.
001511 (2009) Yoon-Suk Lee [Corée du Sud] ; Sun Min Park ; Byeang Hyean KimSynthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
001788 (2005) Jason Paragas [États-Unis] ; Lawrence M. Blatt [États-Unis] ; Chris Hartmann [États-Unis] ; John W. Huggins [États-Unis] ; Tim P. Endy [États-Unis]Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models
001873 (2003) Anna Oevermann [Suisse] ; Monika Engels [Suisse] ; Ursula Thomas [Suisse] ; Antonio Pellegrini [Suisse]The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiviral Agents (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiviral Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021